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Objectives The goal of this study was to evaluate temporal trends in infective endocarditis (IE) incidence and clinical
characteristics after 2002 French IE prophylaxis guideline modifications.
Background There are limited data on changes in the epidemiology of IE since recent guidelines recommended restricting
the indications of antibiotic prophylaxis of IE.
Methods Three 1-year population-based surveys were conducted in 1991, 1999, and 2008 in 3 French regions totaling
11 million inhabitants age 20 years. We prospectively collected IE cases from all medical centers and ana-
lyzed age- and sex-standardized IE annual incidence trends.
Results Overall, 993 expert-validated IE cases were analyzed (323 in 1991; 331 in 1999; and 339 in 2008). IE incidence
remained stable over time (95% confidence intervals given in parentheses/brackets): 35 (31 to 39), 33 (30 to
37), and 32 (28 to 35) cases per million in 1991, 1999, and 2008, respectively. Oral streptococci IE incidence
did not increase either in the whole patient population (8.1 [6.4 to 10.1], 6.3 [4.8 to 8.1], and 6.3 [4.9 to 8.0] in
1991, 1999, and 2008, respectively) or in patients with pre-existing native valve disease. The increased inci-
dence of Staphylococcus aureus IE (5.2 [3.9 to 6.8], 6.8 [5.3 to 8.6], and 8.2 [6.6 to 10.2]) was not significant in
the whole patient population (p  0.228) but was significant in the subgroup of patients without previously
known native valve disease (1.6 [0.9 to 2.7], 3.7 [2.6 to 5.1], and 4.1 [3.0 to 5.6]; p  0.012).
Conclusions Scaling down antibiotic prophylaxis indications was not associated with an increased incidence of oral strepto-
coccal IE. A focus on avoidance of S. aureus bacteremia in all patients, including those with no previously known
valve disease, will be required to improve IE prevention. (J Am Coll Cardiol 2012;59:1968–76) © 2012 by the
American College of Cardiology Foundation
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May 29, 2012:1968–76 Temporal Trends in Infective EndocarditisInfective endocarditis (IE) is a rare but severe disease with
an in-hospital mortality rate of around 20% and a 5-year
mortality rate of 40% (1,2). It also has a high morbidity rate
and cost burden: its treatment requires prolonged hospital-
ization, 1 out of 2 patients is operated on during the acute
phase of the disease, and quality of life and return to work
are compromised in some patients (3,4). Therefore, IE
antibiotic prophylaxis strategies have been proposed for
years worldwide to patients with cardiac diseases at risk
for IE undergoing invasive procedures responsible for
bacteremia (5).
See page 1977
Because no randomized clinical trial had been conducted
to demonstrate the efficacy of such a strategy and because
case-control studies had not found any relationship between
dental procedures and IE (6–8), IE prophylaxis guidelines
were altered toward a drastic reduction in antibiotic indica-
tions, in France as early as 2002 and in other countries in
2007 to 2009 (5,9–13). This change led to restricting the
use of antibiotic prophylaxis to patients with the highest risk
of poor outcomes from IE (i.e., patients with prosthetic
valves, complex congenital heart disease, previous IE). For
example, antibiotic prophylaxis is no longer recommended
for dental procedures in patients with previously known
native valve disease such as mitral valve prolapse or bicuspid
aortic valve. In parallel, general recommendations were
made regarding patients with previously known valve dis-
ease, encouraging better oral and general hygiene and
limiting the use of skin-breaking procedures or indwelling
catheters to limit the risk of staphylococcal IE, the rate of
which has reportedly been increasing (3,14,15). More re-
cently, National Institute for Health and Clinical Excellence
guidelines even recommended discontinuing IE antibiotic
prophylaxis altogether (16).
The evaluation of the impact of this drastic change in IE
prophylaxis strategy on clinical and epidemiological charac-
teristics is complicated by several factors. Due to the
disease’s polymorphic presentation, patients with IE are
managed by physicians of different specializations in sec-
ondary and/or tertiary care hospitals. Patients with the most
severe form of the disease and those needing cardiac surgery
are referred to tertiary care hospitals, where they are
overrepresented (17,18). In addition, the use of administra-
tive coding of discharge data in this evaluation may be
misleading because the data generally represent nonexpert-
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flect financial considerations
rather than those of diagnostic
precision (19,20). Recording IE
characteristic changes with accu-
racy therefore requires large comprehensive population-
based studies, which describe the whole IE patient popula-
tion and are less subject to referral bias (17,18,21).
We had the unique opportunity of having data from 2
previous national population-based surveys with expert-
validated IE cases, performed in 1991 and 1999 before the
modification of IE prophylaxis policy in 2002. We were
thus able to conduct a third survey along the same model
and on the same population pool after the guideline mod-
ifications and then to compare the results of all 3 studies.
The objective was to evaluate temporal trends in IE inci-
dence, clinical characteristics, and prognosis following the
2002 French IE prophylaxis guideline modifications. Par-
ticular attention was paid to oral streptococcal IE incidence,
particularly in patients with previously known native valve
disease, and to staphylococcal IE incidence. The working
hypothesis was that a significant increase in the incidence of
IE after scaling down prophylaxis use would be in favor of
its efficacy, whereas a stable or a decreased incidence of IE
would tend to support the appropriateness of prophylaxis
guideline modifications.
Methods
Population-based survey methods. All three 1-year surveys
(1991, 1999, and 2008) were conducted using the same
methods (2,22). Survey participation packets were sent out
by mail to all physicians potentially involved in IE patient
care, to echocardiographers, and to microbiologists working
in the 3 regions’ hospitals. French societies for infectious
diseases, cardiology, cardiac surgery, and microbiology also
informed their members of the survey. All medical profes-
sionals were asked to report in real time any case of IE,
regardless of diagnostic certainty, and were regularly re-
minded of the study throughout the study period. Duplicate
reports were identified and excluded. Medical professionals
were reminded by “study newsletter” to report regularly. For
each patient age 20 years treated for IE, a specific case
report form was filled out at the hospital and validated by
the primary care physician. Institutional review board au-
thorization was received from the Comité de Protection des
Personnes de Besançon on December 19, 2007.
Case report forms included data on patients’ medical
history (including previously identified cardiac diseases at
risk of IE, procedures at risk of IE performed within the
previous 3 months, and use of antibiotic prophylaxis) and IE
characteristics. Investigators were provided with standard
definitions of all variables. Recent dental procedures were
recorded based on patient report.
Microbiologists completed a form with detailed infor-
Abbreviation
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Temporal Trends in Infective Endocarditis May 29, 2012:1968–76causative microorganism. Identification of streptococcal
and staphylococcal strains was confirmed in the respective
National Reference Centers. All strains were identified at
the species level by genetic methods using gene sequenc-
ing (23,24).
Study populations. The same 3 French regions (Greater
Paris, Lorraine, and Rhône-Alpes) participated in the 3
surveys. They accounted for an 11 million inhabitant pop-
ulation (24% of the French population age20 years). Only
patients 20 years of age with a first hospitalization
between January 1 and December 31 of each year and
residing in these 3 regions were kept in the analysis for
standardized incidence calculations.
Case validation. All case report forms were checked for
accuracy and validated by 3 independent regional assess-
ment committees each composed of an infectious diseases
specialist, a cardiologist, a cardiac surgeon, and a microbi-
ologist. A modified von Reyn classification taking into
account echocardiographic data was used in the 1991, 1999,
and 2008 cases (22,25). Duke classification was also applied
in the 1999 and 2008 cases and the modified Duke
classification in 2008 (26,27). Each patient was also as-
signed to a category in the 3 classifications (modified von
Reyn, Duke, and modified Duke) using a specific applet.
Any discrepancies between computerized and specialists’
classifications were resolved by consensus. The modified von
Reyn classification being the only available classification for
all 3 surveys was chosen to describe the changes over the 3
periods (22). Definite, probable, and possible cases of IE
were considered and compared among the 3 surveys. Sen-
sitivity analyses were performed, one considering only mod-
ified von Reyn definite cases and probable cases, the other
considering the definite cases of the Duke classification for
the 1999 and 2008 cases.
Calculation of incidence and statistical analysis. Inci-
dence rates, expressed as number of cases per million
inhabitants, were calculated by dividing the number of cases
recorded within the study year in the 3 regions by the
number of individuals age 20 years living in these regions.
For each period, incidence rates were standardized to the
sex-by-age distribution of the French population age 20
years. Population references were obtained from the Na-
tional Institute of Statistics and Economic Studies on
January 1, 2008, based on the nationwide 2007 census. IE
standardized incidence rates were also estimated by pre-
planned subgroups: causative micro-organisms (strepto-
cocci, staphylococci), previously known pre-existing cardiac
condition (previously known native underlying heart dis-
ease, prosthetic valve, no previously known underlying heart
disease, and other IE classification criteria (definite and
probable cases according to modified von Reyn classifica-
tion, definite cases according to Duke and modified Duke
classifications). Incidence rates were compared within the 3
surveys using a Poisson regression. Age-and-sex specific
incidences were also calculated for each period. With 300
patients, an incidence of 30 cases per million, and  2-sided 4isk of 5%, a difference of 7 cases per million between
urveys can be detected with a power of 80%.
For descriptive analysis, quantitative variables were ex-
ressed as their mean  SD and qualitative variables
xpressed as percentages. The chi-square test or Fisher exact
est for qualitative variables, and tests stemming from 1-way
nalysis of variance or Kruskal-Wallis test for quantitative
ariables were used for comparisons over the 3 periods.
hen a significant difference was observed for variables
vailable for the 3 periods, a trend test was performed
Cochran-Armitage trend test for binary variables and linear
rend test for quantitative variables). First, factors associated
ith in-hospital mortality were searched for according to
ivariable analysis (logistic regression), first within each
tudy year and then in the whole 3-study population. The
ested variables were those already identified as associated
ith in-hospital mortality in the literature (i.e., age, micro-
rganisms, prosthetic valve, cerebral emboli, cardiac sur-
ery) (1,28–32). Second, 4 multivariable forward stepwise
ogistic regression models were built with an enter p value of
.2 and a remove p value of 0.05. The calendar year effect
1991, 1999, or 2008) was forced in the analysis on the
lobal population. Odds ratios and their 95% confidence
ntervals were calculated. The validity of the models was
hecked using the Hosmer and Lemeshow goodness-of-fit
est. All statistical analyses were performed using SAS
ersion 9.2 (SAS institute, Inc., Cary, North Carolina).
esults
igure 1 shows the case selection process in each of the 3
urveys. There were 323, 331, and 339 patients with a
efinite, probable, or possible IE according to the modified
on Reyn classification, aged 20 years, living in the
tudied regions, and hospitalized during the survey year in
991, 1999, and 2008, respectively. Using the Duke criteria,
here were 323 and 332 definite cases in 1999 and 2008,
espectively.
haracteristics of IE among the 3 surveys. DEMOGRAPHICS,
UNDERLYING HEART DISEASE, AND AT-RISK DENTAL
PROCEDURES. Mean age increased over time from 58 to 62
ears (p 0.013) (Table 1). IE predominated in males in all
surveys; the sex ratio increased significantly over time. The
E incidence rate varied differently according to age and sex
n the 3 surveys (Online Fig. 1). The distribution of
nderlying heart diseases is summarized in Table 1. The
ate of patients with no previously known heart valve disease
ncreased from 34% in 1991 to 49% in 1999 and remained
table in 2008 (47%) (p  0.001). Between 1999 and 2008,
he proportion of patients with prosthetic valves and with
acemakers increased, as did the proportion of patients with
ypertension and diabetes mellitus. The proportion of
ntravenous drug users remained stable. The rate of patients
eporting having had at-risk dental procedures was low and
ot statistically different between 1999 and 2008 (5.1% and
.7%, respectively). Other background characteristics and
E1971JACC Vol. 59, No. 22, 2012 Duval et al.
May 29, 2012:1968–76 Temporal Trends in Infective Endocarditisat-risk dental procedures are displayed in Table 1 and Online
Table 1.
CLINICAL AND BIOLOGICAL EVENTS, LOCATION OF IE, AND
CHOCARDIOGRAPHY. Fever was reported significantly less
frequently over time (Table 1). Severe congestive heart failure
was common. At least one embolic event was reported in 38%,
37%, and 58%, respectively. The proportion of prosthetic valve IE
did not differ significantly among the 3 surveys whereas that of
pacemaker IEs increased significantly. Echocardiography yield
increased significantly over time.
CAUSATIVE MICRO-ORGANISMS. Micro-organisms respon-
sible for IE were identified in 87%, 93%, and 93% from
1991 to 2008 (Table 1). Streptococcaceae were the most
frequent micro-organisms across the 3 surveys, but their
proportion decreased over time. The proportion of group D
streptococci evolved in 2 phases with a marked increase
between 1991 and 1999 (17% to 25%, which explains the
overall streptococci increase between 1991 and 1999) fol-
lowed by a decrease in 2008 to below the 1991 level (12%;
p  0.001). The proportion of Staphylococcus aureus in-
creased regularly and significantly (16%, 21%, and 26%; p
0.011), as did that of coagulase-negative staphylococci (4%,
6%, and 10%; p  0.007). The number of patients having
had an oral procedure in the preceding 3 months and who
developed an oral streptococci IE was low and did not differ
between 1999 and 2008 (6 of 331 [1.8%] and 7 of 339 [2%],
Figure 1 Flowchart of the 1991, 1999, and 2008 Surveys
IE  infective endocarditis; NA  not available; ND  not determined.respectively).OUTCOME. Mean hospital stay duration increased over
time, although not significantly. The rate of cardiac surgery
performed during the acute phase of the disease increased
from 1991 to 1999 (31% to 50%) and then remained stable
(50%) (p  0.001). In-hospital death rates were not
significantly different among the 3 periods (21%, 15%, and
21%, respectively).
Incidence of IE among the 3 surveys. Overall, the age-
and sex-standardized annual IE incidence did not change
significantly across the 3 surveys (Fig. 2, Online Table 2),
but it decreased significantly in patients with previously
known native heart valve disease. The incidence of oral
streptococcal IE did not increase in the overall population or
in the population of patients with previously known native
heart valve disease, in whom it significantly decreased. The
incidence of both S. aureus and coagulase-negative staphy-
lococcal IE increased significantly in patients without pre-
viously known native heart valve disease.
Prognostic factors. Factors associated with in-hospital
mortality are presented in Table 2. In multivariate analysis,
considering the overall population of patients enrolled in the
3 surveys, calendar year was not associated with death,
whereas increasing age, staphylococci, and cerebral emboli
were associated with death. In the models considering the
prognostic factors in each of the surveys, increasing age and
staphylococcal IE were both independently associated with
death in the 3 surveys.
(
3 rmitage
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Despite marked modifications of IE prophylaxis recom-
mendations between 1999 and 2008 toward a reduction of
Temporal Trends in Characteristics of IE (Definite, Probable, and PTable 1 Temporal Trends in Characteristics of IE (Definite, Pro
Characteristic
1991 (n  323)*
n %/Mean SD n
Background characteristics
Age (yrs) 323 57.9 16.6 33
Sex
Men 212 65.6 23
Women 111 34.4 10
Diabetes mellitus NA NA 4
Dialysis NA NA 1
Intravenous drug users 18 5.6 2
Previously known underlying
heart diseases
Previously known underlying
heart disease
212 65.6 16
Native valve disease 170 52.6 11
Mitral valve prolapse 17 5.3
Prosthetic valve 73 22.6 5
Pacemaker 10 3.1 2
IE at-risk dental procedures or situations
Dental oral at risk NA 1
Dental oral at risk in oral
streptococci IE patients
NA
Dental oral at risk with
antibioprophylaxis
NA
Clinical and biological events
Fever 300 94.0 29
Cerebral emboli 46 23.2 5
Cerebral hemorrhage NA
Other emboli 30 15.1 7
Echocardiography
Transesophageal echocardiography 30
Positive echocardiography 249 77.1 29
Vegetation 228 70.6 28
Perforation NA 2
Location of IE
Left heart IE 289 89.5 26
Pacemaker IE NA 1
Prosthetic valve IE 66 20.4 4
Micro-organisms
Streptococcaceae 180 55.7 19
Streptococci 144 44.6 16
Oral streptococci 77 23.8 6
Group D streptococci 54 16.7 8
Staphylococcaceae 67 20.7 9
Staphylococcus aureus 52 16.1 7
Coagulase-negative staphylococci 14 4.3 2
Outcome
Cardiac surgery 99 31.3 16
In-hospital death 63 20.7 5
Values given in bold reflect statistically significant difference. *Considering definite, probable, and p
22). †Chi-square test or Fisher exact test for qualitative variables, test stemming from a 1-way
measures and significant difference in bivariate analysis with an alpha level of 0.05. Cochran-A
IE  infective endocarditis; NA  not available data.antibiotic use, we did not identify any increase either in theoverall incidence rate of IE or in that of oral streptococcal
IE incidence rate. We also observed an increase of staphy-
lococcal IE in a population of patients not identified as at
risk for IE. To our knowledge, this is the first study using a
le IE Using Modified von Reyn Classification), and Possible IE Using Modified von Reyn Classification)
9 (n  331)* 2008 (n  339)*
p
Value†
p
Value‡%/Mean SD n %/Mean SD
59.8 16.5 339 61.6 16.3 0.013 0.021
0.040 0.011
69.8 253 74.6
30.2 86 25.4
13.3 72 21.2 0.006 NA
3.6 6 1.8 0.137 NA
6.3 16 4.7 0.655 NA
50.8 179 52.8 0.002 0.001
34.1 74 21.8 <0.001 <.001
2.1 25 7.4 0.006 0.195
17.5 84 24.8 0.065
6.3 51 15.0 <0.001 <.001
5.1 16 4.7 0.8034 NA
9.8 7 10.0 0.9750 NA
17.6 6 37.5 0.2587 NA
89.0 281 83.9 0.002 <.001
15.1 78 23.0 0.017 0.680
1.2 24 7.1 0.001 NA
22.4 121 35.7 <0.001 <0.001
91.5 307 90.6 0.657
89.4 300 88.5 <0.001 <0.001
84.9 287 84.7 <0.001 <0.001
7.3 71 20.9 <0.001 NA
80.1 260 76.7 <0.001 <0.001
3.3 19 5.6 0.153 NA
13.6 62 18.3 0.061
58.9 167 49.3 0.037 0.089
48.3 128 37.8 0.019 0.071
18.4 70 20.6 0.232
25.1 40 11.8 <0.001 0.087
27.2 122 36.0 <0.001 <0.001
21.1 87 25.7 0.010 0.002
6.0 35 10.3 0.007 0.002
50.2 168 49.6 <0.001 <0.001
15.4 72 21.2 0.110
IE cases according to modified von Reyn classification taking into account echocardiographic data
s of variance or Kruskal-Wallis test for quantitative variables. ‡Trend test only for variables with
trend test calculated for binary variables and linear trend test for quantitative variable.ossibbable
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analysilarge population-based survey, which analyzes IE epidemi-
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May 29, 2012:1968–76 Temporal Trends in Infective Endocarditisology evolution after the recent drastic restrictions in IE
prophylaxis indications.
Population-based surveys most accurately analyze IE
characteristics because they avoid major referral bias (2,15).
The rarity of this disease, concern about its diagnosis, and
the diversity of physicians potentially involved make exhaus-
tive data collection difficult. Studies describing temporal
changes in IE characteristics necessitate either prolonged
longitudinal follow-up of a predefined and usually small
population pool or repeated temporal cross-sectional surveys
providing an intensive, time-limited assessment of a larger
population pool. We chose the latter approach to collect
very large samples of IE cases (several hundred) among a
population of 11 million (one fifth of the total French
population) over three 1-year periods.
Increase in the incidence of staphylococci IE. This tem-
poral comparison underlines the evolving nature of IE
despite the stability of the incidence rate, with an aging
population with increasing rates of comorbidities. On the
contrary, the rate of patients with pre-existing native valve
diseases has more than halved in 18 years (1 in 5 patients in
2008). This evolving nature of IE is also reflected by its
microbiological profile. Whereas there are contradictory
data on the evolution of micro-organisms responsible for
IE, our study provides clear evidence of the increase of both
Figure 2 Temporal Trends in IE Age- and Sex-Standardized Inci
and According to Underlying Heart Disease and Micro
IE  infective endocarditis.S. aureus and coagulase-negative staphylococci IE rates andincidences. This increase may not be attributed to referral
bias, to a modification of intravenous drug use prevalence
(because its rate remained stable over time), or to an increase
of S. aureus IE due to community-acquired methicillin-
resistant clones (none were isolated in the 2008 survey). The
increased incidence of staphylococci must be considered in
the light of the increased number of patients with prosthetic
valve IE, pacemaker IE, diabetes mellitus, all conditions
associated with staphylococcal bacteremia. This is consistent
with the significant increase in the rate of cerebral and
peripheral emboli, identified as more frequent in patients
with staphylococcal IE (33). When considering staphyloc-
cocal IE incidence change, the only statistically significant
increase concerned staphylococcal IE cases occurring in
patients with no previously known valvular diseases, a
population not targeted by IE prophylaxis.
Stability of streptococcal IE. Streptococcal IE incidence
did not increase between 1999 and 2008, despite IE
antibiotic prophylaxis indications being discontinued for
most patients since 2002 in France. These results are
consistent with those of a recent study conducted in the
United Kingdom that excluded any large increase in the
incidence of IE in the 2 years after the U.K. National
Institute for Health and Clinical Excellence guideline mod-
ifications, which were implemented by dentists and physi-
for All Micro-Organisms
nismsdence
-orgacians (20). This compliance with the modified guidelines
1974 Duval et al. JACC Vol. 59, No. 22, 2012
Temporal Trends in Infective Endocarditis May 29, 2012:1968–76was depicted by a drastic decrease in the number of
prescribed antibiotic prophylaxis assessed through National
Health Service medication reimbursement data. However,
their data on IE incidence originated from codified dis-
charge diagnosis data, not from expert-validated diagnostic
classification, which presents several limitations. Notably,
this method permits the description of broad general ten-
dencies but is unable to provide precise analysis of epide-
miological evolution including microbial modification.
We observed this reassuring absence of increases in
streptococci IE incidence both in the overall population of
IE patients and in patients with previously known native
valve heart disease (i.e., those for whom IE prophylaxis was
no longer recommended after the 2002 French IE prophy-
laxis guidelines). In addition, similar findings resulted using
different case definitions (modified von Reyn or Duke
classifications). Our evaluation of incidence evolution is
based on a highly accurate estimation of streptococcal IE
incidence. First, each streptococcal strain identification was
Factors Associated With In-Hospital Mortality in Each of the 3 Surv(1991, 1999, and 2008) and in the Po led Survey PopulationTable 2 Fac ors Associated With In-Hospital Mortality n Each(1991, 1999, and 2008) and in the Pooled Survey Pop
Factor N
In-Hospital Death
n % Odds R
Age (yr)
1991 305 63 20.7 1.0
1999 331 51 15.4 1.0
2008 339 72 21.2 1.0
1991–1999–2008 975 186 19.1 1.0
Prosthetic valve
1991 69 23 33.3 2.4
1999 58 13 22.4 1.7
2008 84 20 23.8 1.2
1991–1999–2008 211 56 26.5 1.7
Staphylococcaceae*
1991 62 23 37.1 2.9
1999 90 27 30.0 3.8
2008 122 43 35.2 3.5
1991–1999–2008 274 93 33.9 3.3
Cerebral emboli
1991 43 14 32.6 2.2
1999 50 8 16.0 1.0
2008 78 26 33.3 2.3
1991–1999–2008 171 48 28.1 1.9
Cardiac surgery
1991 94 21 22.3 1.1
1999 166 17 10.2 0.4
2008 168 30 17.9 0.6
1991–1999–2008 428 68 15.9 0.6
Survey year †
1991 305 63 20.7 1.0
1999 331 51 15.4 0.7
2008 339 72 21.2 1.0
Four statistical models were built, 1 for each of the 3 surveys and the last one for the pooled popula
to nonsignificant characteristics in the multivariate regression model. *Staphylococcaceae gro
†Variables analyzed only in the model pooling the 3 surveys.
CI  confidence interval.cross-validated by the national reference center for strepto-cocci. Second, all IE cases were checked by a multidisci-
plinary adjudication committee leading to the exclusion of a
high number of cases initially considered as potential IE by
the primary care physicians. This process underlines both
the difficulty of IE diagnosis and, in epidemiological sur-
veillance, the need for critical and careful appraisal of data
from inpatient charts, which represent nonexpert-validated
IE cases (19). In addition, the 3 surveys were conducted by
the same group of investigators, using similar methods and
classifications, thus limiting the risks of definition biases.
We cannot definitely claim that IE prophylaxis modification
did not lead to an increase in the incidence of oral
streptococcal IE; given the low number of streptococcal IE
in patients with previously known heart disease, the limited
number of cases collected would have allowed us to detect
only a major increase in IE incidence in this group of
patients. Furthermore, the stability of streptococcal IE
incidence despite IE antibiotic prophylaxis reduction for
bucco-dental procedures could reflect practitioners’ lack of
e 3 Surveys
on
Bivariate Regression Multivariate Regression
95% CI p Value Odds Ratio 95% CI
1.01–1.05 0.003 1.03 1.00–1.05
1.01–1.06 0.001 1.04 1.02–1.07
1.02–1.06 0.001 1.05 1.02–1.07
1.02–1.04 0.001 1.04 1.03–1.05
1.34–4.49 0.004 2.56 1.13–5.84
0.88–3.62 0.118
0.68–2.19 0.510
1.23–2.52 0.002
1.62–5.55 0.001 3.11 1.38–7.00
2.09–7.18 0.001 5.29 2.73–10.26
2.06–6.05 0.001 3.95 2.23–7.00
2.41–4.68 0.001 4.15 2.84–6.06
1.04–4.83 0.042
0.46–2.40 0.900
1.32–4.13 0.004 2.90 1.55–5.42
1.32–2.87 0.001 2.00 1.31–3.03
0.64–2.08 0.643
0.23–0.82 0.008
0.39–1.13 0.130
0.49–0.95 0.023
0.104 1.00
0.47–1.05 0.56 0.34–0.92
0.71–1.52 0.65 0.40–1.05
975 patients. The survey year variable was only included in the last model. Blank cells correspond
udes Staphylococcus aureus, coagulase-negative staphylococci, and other staphylococcaceae.eysof th
ulati
atio
3
3
4
3
5
9
2
6
9
8
3
6
5
5
4
5
5
4
7
9
0
0
4
tion of
up inclcompliance with these new recommendations. However, in
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awareness of the 2002 IE prophylaxis recommendations and
60% declared having modified their use of prophylaxis
accordingly.
IE prognosis evolution. Despite the general improvement
in patients’ medical care, IE prognosis did not improve
between 1991 and 2008. The in-hospital mortality rate
remained as high as 20%. When analyzing prognostic
factors in the total population of 975 patients, mortality
tended to be lower in 2008 and 1999 compared with 1991
in multivariate analysis. When considering each year in 3
distinct analyses, age and staphylococcal IE were indepen-
dently associated with mortality in 1991, 1999, and 2008.
Study limitations. We must acknowledge some limitations
to our study. First, underreporting is a potential limitation
when relying on physician report and not on investigators’
active search for cases. In our study, underreporting was
minimized through reliance on 3 separate notification
sources (physicians, echocardiographers, and microbiolo-
gists). The rate of unreturned case report was low in each
survey, between 1% and 2%. To lighten physicians’ work
load and encourage reporting, specially trained clinical
research assistants were assigned to facilitate the reporting
procedure. Furthermore, the proportion of patients living
within one of the study regions and treated for IE outside
these regions was 5%, based on the French national
database file of diagnosis-related groups as classified at
hospital discharge. Second, the IE classification in use at the
time of each survey was different and based partially on
different data. Because retrospective classifying 1991 and
1998 surveys using the modified Duke classification was
impossible, we categorized all our cases using the modified
von Reyn classification to permit temporal comparisons.
Because the same classification was used for the 3 surveys, it
limited the risk of a differential bias. Furthermore, to
validate our result, we took into account both comparisons
based on broad case definitions and those based on more
restricted case definitions; comparison of the 1999 to 2008
temporal trends (surrounding the 2002 guidelines modifi-
cation) using both modified von Reyn and Duke classifica-
tions revealed no discrepancies (Online Tables 3 and 4). Of
note, there was no statistically significant difference in the
incidences of IE in 2008 using the different classifications.
Third, the comparison of IE incidence between the 1991
and 2008 time intervals may be biased by an improvement
in IE diagnosis performance due to medical progress (im-
provement in echocardiographic or microbiological tech-
niques increasing their sensitivity and the diagnosis of IE),
which could artificially inflate reported IE incidence. The
stability in IE incidence observed in our study over time
should therefore be interpreted with caution. Finally, dif-
ferences among countries in the incidence of IE, in the
proportion of the micro-organisms responsible, and in the
IE prophylaxis guidelines may influence the generalizability
of the study results. However, we think that the results may
reasonably be extrapolated to most industrialized countries.Conclusions
IE co-evolved with socioeconomic changes and medical
progress, leading to an increase of onset age, co-morbidities,
intracardiac devices, and of staphylococcal IE. A high and
stable in-hospital mortality rate was associated with age and
staphylococci, two characteristics which rates have both
increased over the last 2 decades. Given the poor prognosis
of S. aureus IE and its increasing incidence, S. aureus
bacteremia prevention is necessary in patients with previ-
ously known valve diseases but also in patients without such
disease in whom IE incidence has increased most. So far,
changes in IE antibiotic prophylaxis guidelines have not given
rise to an increase in oral streptococci IE, which supports a
posteriori the reduction of its use. This fact should prompt a
decrease in the unnecessary consumption of antibiotics, a
source of ever-increasing bacterial resistance.
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